Skip header and navigation

Narrow By

51 records – page 2 of 3.

Induction of labour and cervical ripening with oral misoprostol (prostaglandin E1) (Cytotec)

https://libcat.nshealth.ca/en/permalink/chpams35821
Nova Scotia Health Authority. Women and Children's Health. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1771
Available Online
View Pamphlet
Misoprostol is a pill that contains a medication called prostaglandin E1. Prostaglandin E1 softens the cervix to get it ready for labour and to cause labour contractions. Cytotec® is the brand name of this medication. This pamphlet explains what to expect when you get misoprostol, possible complications of misoprostol, and when you should notify a member of your health care team. The French version of this pamphlet 1816, "Déclenchement artificiel du travail et maturation cervicale au moyen de c…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health
Alternate Title
Induction of labor and cervical ripening with oral misoprostol (prostaglandin E1) (Cytotec)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Misoprostol
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Misoprostol is a pill that contains a medication called prostaglandin E1. Prostaglandin E1 softens the cervix to get it ready for labour and to cause labour contractions. Cytotec® is the brand name of this medication. This pamphlet explains what to expect when you get misoprostol, possible complications of misoprostol, and when you should notify a member of your health care team. The French version of this pamphlet 1816, "Déclenchement artificiel du travail et maturation cervicale au moyen de comprimés oraux de misoprostol (prostaglandine E1) (Cytotec®)", is also available.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1771
Less detail

Déclenchement artificiel du travail et maturation cervicale au moyen d’une insertion vaginale de dinoprostone (Cervidil)

https://libcat.nshealth.ca/en/permalink/chpams35879
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1815
Available Online
View Pamphlet
Cervidil® est un dispositif mince et plat, comme un tampon. Il contient un médicament appelé dinoprostone. La dinoprostone est comme une substance naturelle produite par votre corps. Elle assouplit le col de votre utérus pour le préparer au travail. Le présent dépliant explique à quoi vous attendre comme suite à l’utilisation d’une insertion vaginale Cervidil®, les complications possibles et quand appeler l’hôpital ou y retourner. ; This pamphlet is a French translation of "Induction of Labour …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit
Alternate Title
Induction of labour and cervical ripening with Dinoprostone vaginal insert (Cervidil®)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Dinoprostone
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Cervidil® est un dispositif mince et plat, comme un tampon. Il contient un médicament appelé dinoprostone. La dinoprostone est comme une substance naturelle produite par votre corps. Elle assouplit le col de votre utérus pour le préparer au travail. Le présent dépliant explique à quoi vous attendre comme suite à l’utilisation d’une insertion vaginale Cervidil®, les complications possibles et quand appeler l’hôpital ou y retourner.
This pamphlet is a French translation of "Induction of Labour and Cervical Ripening with Dinoprostone Vaginal Insert (Cervidil®)" pamphlet 1770. Cervidil® is a thin, flat insert, like a tampon. It contains medication called dinoprostone. Dinoprostone is like a natural substance made by your body. It softens your cervix to get it ready for labour. This pamphlet explains what to expect when you get Cervidil®, possible complications of Cervidil®, and when you should call or return to the hospital.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1815
Less detail

Déclenchement artificiel du travail et maturation cervicale au moyen de comprimés oraux de misoprostol (prostaglandine E1) (Cytotec)

https://libcat.nshealth.ca/en/permalink/chpams35880
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1816
Available Online
View Pamphlet
Le misoprostol est une pilule qui contient un médicament appelé prostaglandine E1. La prostaglandine E1 assouplit le col de l’utérus pour le préparer au travail et déclencher des contractions. Cytotec® est le nom de marque de ce médicament. Le présent dépliant explique à quoi s'attendre si vous prenez du misoprostol, les complications possibles et quand informer un membre de votre équipe de soins de santé. ; This pamphlet is a French translation of "Induction of Labour and Cervical Ripening wit…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit
Alternate Title
Induction of labour and cervical ripening with oral misoprostol (prostaglandin E1) (Cytotec®)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Misoprostol
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Le misoprostol est une pilule qui contient un médicament appelé prostaglandine E1. La prostaglandine E1 assouplit le col de l’utérus pour le préparer au travail et déclencher des contractions. Cytotec® est le nom de marque de ce médicament. Le présent dépliant explique à quoi s'attendre si vous prenez du misoprostol, les complications possibles et quand informer un membre de votre équipe de soins de santé.
This pamphlet is a French translation of "Induction of Labour and Cervical Ripening with Oral Misoprostol (Prostaglandin E1) (Cytotec®)" pamphlet 1771. Misoprostol is a pill that contains a medication called prostaglandin E1. Prostaglandin E1 softens the cervix to get it ready for labour and to cause labour contractions. Cytotec® is the brand name of this medication. This pamphlet explains what to expect when you get misoprostol, possible complications of misoprostol, and when you should notify a member of your health care team.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1816
Less detail

Medical abortion

https://libcat.nshealth.ca/en/permalink/chpams35888
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1831
Available Online
View Pamphlet
This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included. The French version of this pamphlet 1861, "Avortement par médicaments", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Abortion
Pregnancy, Unwanted
Specialty
Gynecology
Abstract
This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included. The French version of this pamphlet 1861, "Avortement par médicaments", is also available.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1831
Less detail

Procedural abortion

https://libcat.nshealth.ca/en/permalink/chpams35889
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1832
Available Online
View Pamphlet
This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedural abortion, and possible risks. What to expect after you go home and who to contact for further information is included. The French version of this pamphlet 1862, "Avortement par instruments", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Surgical abortion
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Pregnancy, Unwanted
Abortion
Specialty
Gynecology
Abstract
This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedural abortion, and possible risks. What to expect after you go home and who to contact for further information is included. The French version of this pamphlet 1862, "Avortement par instruments", is also available.
Notes
Previous title: Surgical abortion
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1832
Less detail

Avortement par médicaments

https://libcat.nshealth.ca/en/permalink/chpams35925
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1861
Available Online
View Pamphlet
La présente brochure explique ce qu’est l’avortement par médicaments, qui peut avoir un avortement par médicaments, ce qui se passe durant l’intervention et les risques et effets secondaires possibles. Vous y trouverez des instructions pour prendre le médicament Mifegymiso afin de provoquer un avortement par médicaments et les coordonnées pour obtenir plus d'information. ; This pamphlet is a French translation of "Medical Abortion" pamphlet 1831. This pamphlet explains what a medical abortion i…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Medical abortion
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Pregnancy, Unwanted
Abortion
Specialty
Gynecology
Abstract
La présente brochure explique ce qu’est l’avortement par médicaments, qui peut avoir un avortement par médicaments, ce qui se passe durant l’intervention et les risques et effets secondaires possibles. Vous y trouverez des instructions pour prendre le médicament Mifegymiso afin de provoquer un avortement par médicaments et les coordonnées pour obtenir plus d'information.
This pamphlet is a French translation of "Medical Abortion" pamphlet 1831. This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included.
Notes
Previous title: Avortement médicamenteux
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1861
Less detail

Avortement par instruments

https://libcat.nshealth.ca/en/permalink/chpams35931
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1862
Available Online
View Pamphlet
La présente brochure explique ce qu’est l’avortement par instruments, qui peut avoir un avortement par instruments, ce qui se passe durant l’intervention et les risques possibles. On y indique ce à quoi vous attendre après votre retour à la maison et qui contacter pour de plus amples renseignements. ; This pamphlet is a French translation of "Procedural Abortion" pamphlet 1832. This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedu…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Procedural abortion
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Pregnancy, Unwanted
Abortion
Specialty
Gynecology
Abstract
La présente brochure explique ce qu’est l’avortement par instruments, qui peut avoir un avortement par instruments, ce qui se passe durant l’intervention et les risques possibles. On y indique ce à quoi vous attendre après votre retour à la maison et qui contacter pour de plus amples renseignements.
This pamphlet is a French translation of "Procedural Abortion" pamphlet 1832. This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedural abortion, and possible risks. What to expect after you go home and who to contact for further information is included.
Notes
Previous title: Avortement chirurgical
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1862
Less detail

Medical abortion (Mifegymiso) instructions

https://libcat.nshealth.ca/en/permalink/chpams35935
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1878
Available Online
View Pamphlet
This pamphlet explains how to take the medication Mifegymiso to cause an abortion. It lists the supplies you will need, how to take the medications, and symptoms that require you to call the Nova Scotia Choice Clinic Nursing Line. Information about sex and birth control after taking Mifegymiso, and follow-up care is provided. The French version of this pamphlet 1886, "Directives pour un avortement par médicaments (Mifegymiso)," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Abortion
Pregnancy, Unwanted
Specialty
Gynecology
Abstract
This pamphlet explains how to take the medication Mifegymiso to cause an abortion. It lists the supplies you will need, how to take the medications, and symptoms that require you to call the Nova Scotia Choice Clinic Nursing Line. Information about sex and birth control after taking Mifegymiso, and follow-up care is provided. The French version of this pamphlet 1886, "Directives pour un avortement par médicaments (Mifegymiso)," is also available.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1878
Less detail

Après votre intervention

https://libcat.nshealth.ca/en/permalink/chpams36741
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2109
Available Online
View Pamphlet
Le dépliant fournit des instructions à suivre après votre avortement, dont une liste des choses à éviter pendant 24 heures (une journée). Vous y trouverez une liste des symptômes qui exigent des soins médicaux, ainsi que de l’information sur la prévention de l’infection, le retour à la maison et les personnes à joindre si vous avez des questions. On vous propose un lien vers un questionnaire de rétroaction et les coordonnées pour obtenir du counseling gratuit. ; This pamphlet is a French transl…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Après votre avortement
After your procedure
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([6] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Abortion
Pregnancy, Unwanted
Specialty
Gynecology
Abstract
Le dépliant fournit des instructions à suivre après votre avortement, dont une liste des choses à éviter pendant 24 heures (une journée). Vous y trouverez une liste des symptômes qui exigent des soins médicaux, ainsi que de l’information sur la prévention de l’infection, le retour à la maison et les personnes à joindre si vous avez des questions. On vous propose un lien vers un questionnaire de rétroaction et les coordonnées pour obtenir du counseling gratuit.
This pamphlet is a French translation of "After Your Procedure" pamphlet 1509. Instructions for after your abortion are given, including a list of activities to avoid for 24 hours (1 day). A list of symptoms that require medical attention is provided. Information on preventing infection, what to expect after you go home, and who to contact if you have questions is given. A link to a feedback survey and contact information for free counselling is provided.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
2109
Less detail

About the Baby-Friendly Initiative and Infant Feeding Policy

https://libcat.nshealth.ca/en/permalink/chpams38215
Nova Scotia Health Authority. South Shore Regional Hospital. Women and Children Health Services. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2365
Available Online
View Pamphlet
The Baby-Friendly Initiative (BFI) is an international program created to support parents, babies, and families by supporting families to make an informed decision about how they feed their baby, promoting practices that give parents and babies a healthy start, and protecting families from marketing pressures. All hospitals and public health units in Nova Scotia Health are working towards becoming designated as Baby-Friendly. The IWK became designated in 2019. This pamphlet explains what staff …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. South Shore Regional Hospital. Women and Children Health Services
Alternate Title
About the BFI and IFP
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Infant
Nutrition
Breast Feeding
Subjects (LCSH)
Infants--Nutrition
Breastfeeding
Specialty
Gynecology
Abstract
The Baby-Friendly Initiative (BFI) is an international program created to support parents, babies, and families by supporting families to make an informed decision about how they feed their baby, promoting practices that give parents and babies a healthy start, and protecting families from marketing pressures. All hospitals and public health units in Nova Scotia Health are working towards becoming designated as Baby-Friendly. The IWK became designated in 2019. This pamphlet explains what staff at a Baby-Friendly facility will help you to do. It also gives information about Nova Scotia Health and IWK Health's Infant Feeding Policy. A link for more information is included.
Responsibility
Prepared by: Women and Children Health Services, South Shore Regional Hospital
Pamphlet Number
2365
Less detail

After vulvar biopsy or excision

https://libcat.nshealth.ca/en/permalink/chpams35624
Nova Scotia Health Authority. Central Zone. Gynecolposcopy Clinic. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1625
Available Online
View Pamphlet
This sheet provides general skin care instructions for after a vulvar biopsy or vulvar excision.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gynecolposcopy Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Vulvar Neoplasms - diagnosis
Vulvar Diseases - diagnosis
Subjects (LCSH)
Vulva--Diseases
Specialty
Gynecology
Abstract
This sheet provides general skin care instructions for after a vulvar biopsy or vulvar excision.
Responsibility
Prepared by: Gynecolposcopy Clinic
Pamphlet Number
1625
Less detail

Induction of labour and cervical ripening with balloon catheter

https://libcat.nshealth.ca/en/permalink/chpams35819
Nova Scotia Health Authority. Women and Children's Health. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1769
Available Online
View Pamphlet
A balloon catheter is a soft tube with a small balloon on the end. The balloon catheter helps to get your cervix ready for labour (cervical ripening). This pamphlet explains what will happen when the balloon catheter is inserted (put in), possible complications of a balloon catheter, and when you should call or return to the hospital. The French version of this pamphlet 1814, "Déclenchement artificiel du travail et maturation cervicale au moyen d’un cathéter à ballonnet", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health
Alternate Title
Induction of labor and cervical ripening with balloon catheter
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Catheters
Subjects (LCSH)
Labor (Obstetrics)
Catheters
Specialty
Gynecology
Abstract
A balloon catheter is a soft tube with a small balloon on the end. The balloon catheter helps to get your cervix ready for labour (cervical ripening). This pamphlet explains what will happen when the balloon catheter is inserted (put in), possible complications of a balloon catheter, and when you should call or return to the hospital. The French version of this pamphlet 1814, "Déclenchement artificiel du travail et maturation cervicale au moyen d’un cathéter à ballonnet", is also available.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1769
Less detail

Déclenchement artificiel du travail et maturation cervicale au moyen d’un cathéter à ballonnet

https://libcat.nshealth.ca/en/permalink/chpams35878
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1814
Available Online
View Pamphlet
Un cathéter à ballonnet est un tube souple muni d’un petit ballonnet à l’extrémité. Le cathéter à ballonnet aide à préparer le col de votre utérus pour le travail (maturation cervicale ou du col). Le présent dépliant explique ce qui se passe quand le cathéter à ballonnet est inséré (mis en place), les complications possibles et quand appeler l’hôpital ou y revenir. ; This pamphlet is a French translation of "Induction of labour and cervical ripening with balloon catheter" pamphlet 1769. A ballo…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit
Alternate Title
Induction of labour and cervical ripening with balloon catheter
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Catheters
Subjects (LCSH)
Labor (Obstetrics)
Catheters
Specialty
Gynecology
Abstract
Un cathéter à ballonnet est un tube souple muni d’un petit ballonnet à l’extrémité. Le cathéter à ballonnet aide à préparer le col de votre utérus pour le travail (maturation cervicale ou du col). Le présent dépliant explique ce qui se passe quand le cathéter à ballonnet est inséré (mis en place), les complications possibles et quand appeler l’hôpital ou y revenir.
This pamphlet is a French translation of "Induction of labour and cervical ripening with balloon catheter" pamphlet 1769. A balloon catheter is a soft tube with a small balloon on the end. The balloon catheter helps to get your cervix ready for labour (cervical ripening). This pamphlet explains what will happen when the balloon catheter is inserted (put in), possible complications of a balloon catheter, and when you should call or return to the hospital.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1814
Less detail

Birth control medication interaction with sugammadex (Bridion®)

https://libcat.nshealth.ca/en/permalink/chpams36680
Nova Scotia Health Authority. Department of Anesthesia. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2076
Available Online
View Pamphlet
During your surgery, you were given a medication that affects how well birth control medications work. It is important that you know this if you are on any type of hormonal contraceptive (birth control medication). Sugammadex (Bridion®) is a medication that helps you recover faster from the muscle relaxant used during your surgery. Sugammadex may lower how well your hormonal birth control works for 7 days (1 week). Use a back-up birth control method for at least 7 days after your surgery. If yo…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Department of Anesthesia
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Sugammadex - adverse effects
Hormonal Contraception
Subjects (LCSH)
Birth control
Sugammadex
Specialty
Gynecology
Abstract
During your surgery, you were given a medication that affects how well birth control medications work. It is important that you know this if you are on any type of hormonal contraceptive (birth control medication). Sugammadex (Bridion®) is a medication that helps you recover faster from the muscle relaxant used during your surgery. Sugammadex may lower how well your hormonal birth control works for 7 days (1 week). Use a back-up birth control method for at least 7 days after your surgery. If you are using an oral contraceptive (birth control pill), take it as usual. Types of hormonal birth control and back-up methods are listed. The French version of this pamphlet 2202, "Interaction des contraceptifs avec le sugammadex (Bridion™)", is also available.
Notes
Previous title: Birth control medication interaction with sugammadex (Bridion™)
Responsibility
Prepared by: Department of Anesthesia
Pamphlet Number
2076
Less detail

Getting enough iron during pregnancy

https://libcat.nshealth.ca/en/permalink/chpams38168
Nova Scotia Health Authority. South Shore Regional Hospital. OBS Clinic. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2330
Available Online
View Pamphlet
Iron helps your blood carry oxygen through your body. When your iron levels are too low, you can develop a condition called iron deficiency anemia. This can lead to serious health issues. A person who is pregnant needs more iron to support the growth of their baby. During pregnancy, you need about one third (1/3) more iron. This pamphlet explains how much iron you need each day, how you can make sure you get enough iron, and how you will know if you are getting enough iron. Space is included fo…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. South Shore Regional Hospital. OBS Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Iron, Dietary
Pregnancy
Subjects (LCSH)
Iron in human nutrition
Pregnancy
Specialty
Gynecology
Abstract
Iron helps your blood carry oxygen through your body. When your iron levels are too low, you can develop a condition called iron deficiency anemia. This can lead to serious health issues. A person who is pregnant needs more iron to support the growth of their baby. During pregnancy, you need about one third (1/3) more iron. This pamphlet explains how much iron you need each day, how you can make sure you get enough iron, and how you will know if you are getting enough iron. Space is included for your health care team to record your hemoglobin and ferritin levels. Instructions on how to take elemental iron are given.
Responsibility
Prepared by: OBS Clinic, South Shore Regional Hospital
Pamphlet Number
2330
Less detail

Neonatal abstinence syndrome

https://libcat.nshealth.ca/en/permalink/chpams36769
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2144
Available Online
View Pamphlet
Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home. The French version of this pamphlet 2203, "Syndrome de sevrage néonatal," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group
Alternate Title
NAS
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Neonatal Abstinence Syndrome
Subjects (LCSH)
Newborn infants--Effect of drugs on
Specialty
Gynecology
Abstract
Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home. The French version of this pamphlet 2203, "Syndrome de sevrage néonatal," is also available.
Responsibility
Prepared by: Women and Children's Provincial Policy Working Group
Pamphlet Number
2144
Less detail

Cervical Screening Practice Guidelines

https://libcat.nshealth.ca/en/permalink/chpams37421
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2019.
Pamphlet Number
1677
Available Online
View Pamphlet
Guidelines for cervical screening are explained, including who should be screened and how frequently. Those who should be screened more frequently are outlined.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (2 p.) : digital, PDF file
Subjects (MeSH)
Uterine Cervical Neoplasms - diagnosis
Subjects (LCSH)
Cervix uteri--Cancer--Diagnosis
Specialty
Diagnosis
Gynecology
Abstract
Guidelines for cervical screening are explained, including who should be screened and how frequently. Those who should be screened more frequently are outlined.
Notes
Health professional guide
Responsibility
prepared by Nova Scotia Health Authority Cancer Care Program
Pamphlet Number
1677
Less detail

Patient passport : gynecologic oncology surgery

https://libcat.nshealth.ca/en/permalink/chpams37445
Nova Scotia Health Authority. Cancer Care Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2024.
Pamphlet Number
4001
Available Online
View Pamphlet
This pamphlet gives information about your gynecologic oncology surgery. There is space for you to fill in information for you and your health care team. Please bring this passport with you to your pre-admission appointment and on the day of your surgery.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cancer Care Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Genital Neoplasms, Female - surgery
Subjects (LCSH)
Generative organs, Female--Cancer--Surgery
Specialty
Gynecology
Abstract
This pamphlet gives information about your gynecologic oncology surgery. There is space for you to fill in information for you and your health care team. Please bring this passport with you to your pre-admission appointment and on the day of your surgery.
Responsibility
Prepared by: Nova Scotia Health Cancer Care ProgramProgram, modified from and with many thanks to the IWK patient passport, in conjunction with the RECOVER Study.
Pamphlet Number
4001
Less detail

Syndrome de sevrage néonatal

https://libcat.nshealth.ca/en/permalink/chpams37507
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2203
Available Online
View Pamphlet
Le syndrome de sevrage néonatal (ou syndrome de sevrage du bébé) se produit lorsqu’un nouveau né est privé d’un médicament que sa mère prenait pendant sa grossesse. Ce dépliant explique les symptômes courants, ce que l’équipe de soins fera pour aider votre bébé, ce que vous pouvez faire pour aider votre bébé, ce qui se passera si votre bébé a besoin de médicaments pour traiter ses symptômes et quand votre bébé pourra rentrer à la maison. ; This pamphlet is a French translation of the English pa…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group
Alternate Title
Neonatal abstinence syndrome
NAS
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Neonatal Abstinence Syndrome
Subjects (LCSH)
Newborn infants--Effect of drugs on
Specialty
Gynecology
Abstract
Le syndrome de sevrage néonatal (ou syndrome de sevrage du bébé) se produit lorsqu’un nouveau né est privé d’un médicament que sa mère prenait pendant sa grossesse. Ce dépliant explique les symptômes courants, ce que l’équipe de soins fera pour aider votre bébé, ce que vous pouvez faire pour aider votre bébé, ce qui se passera si votre bébé a besoin de médicaments pour traiter ses symptômes et quand votre bébé pourra rentrer à la maison.
This pamphlet is a French translation of the English pamphlet 2144, "Neonatal abstinence syndrome". Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home.
Responsibility
Prepared by: Women and Children's Provincial Policy Working Group
Pamphlet Number
2203
Less detail
Nova Scotia Health Authority. QEII. Gynaecology. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1553
Available Online
View Pamphlet
A molar pregnancy is a rare condition that can happen during pregnancy. It is part of a number of conditions that together are called gestation trophoblastic disease (GTD). This pamphlet explains what causes a molar pregnancy, who can get it, diagnosis, treatment, test results, as well as answering questions you may have about getting pregnant again after experiencing a molar pregnancy. If you have any questions, a contact number is provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Gynaecology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Hydatidiform Mole
Gestational Trophoblastic Disease
Subjects (LCSH)
Molar pregnancy
Gestational trophoblastic disease
Specialty
Gynecology
Abstract
A molar pregnancy is a rare condition that can happen during pregnancy. It is part of a number of conditions that together are called gestation trophoblastic disease (GTD). This pamphlet explains what causes a molar pregnancy, who can get it, diagnosis, treatment, test results, as well as answering questions you may have about getting pregnant again after experiencing a molar pregnancy. If you have any questions, a contact number is provided.
Responsibility
Prepared by: Department of Obstetrics and Gynaecology
Pamphlet Number
1553
Less detail

51 records – page 2 of 3.